drugset
drugset / Trial / NCT05414591

Pharmacokinetics and Safety Following Administration of DWP16001

NCT05414591 ↗

Phase 1 Completed 38 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedCrossoverOpen-labelTreatment

Summary

To compare and evaluate the safety and pharmacokinetic characteristics after administration of DWP16001 Drug A and DWP16001 Drug B in healthy adult volunteers

Timeline

Start
2021-05-01
Primary completion
2021-08-01
Completion
2021-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject DWP16001 Drug A Unknown — Oral
Subject DWP16001 drug B Unknown — Oral

Indications

No indication recorded.